JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 131 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 5.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $119,000 | -90.6% | 39,339 | -76.8% | 0.00% | -100.0% |
| Q3 2021 | $1,261,000 | -26.3% | 169,686 | -32.5% | 0.01% | -37.5% |
| Q2 2021 | $1,710,000 | +75.7% | 251,478 | +165.4% | 0.01% | +100.0% |
| Q1 2021 | $973,000 | +67.2% | 94,739 | +12.3% | 0.00% | 0.0% |
| Q2 2020 | $582,000 | -52.2% | 84,369 | -67.1% | 0.00% | -66.7% |
| Q1 2020 | $1,217,000 | -70.6% | 256,139 | -45.9% | 0.01% | -57.1% |
| Q4 2019 | $4,134,000 | +4597.7% | 473,565 | +1721.5% | 0.03% | +2700.0% |
| Q4 2018 | $88,000 | – | 25,999 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 572,829 | $1,340,000 | 100.00% |
| TRV GP III, LLC | 1,148,780 | $2,688,000 | 1.17% |
| COWEN AND COMPANY, LLC | 3,647,430 | $8,535,000 | 0.82% |
| Octagon Capital Advisors LP | 1,400,000 | $3,276,000 | 0.56% |
| Deep Track Capital, LP | 4,259,653 | $9,968,000 | 0.46% |
| PFM Health Sciences, LP | 4,094,488 | $9,581,000 | 0.35% |
| RTW INVESTMENTS, LP | 5,106,341 | $11,949,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $645,000 | 0.24% |
| Monarch Partners Asset Management LLC | 228,370 | $534,000 | 0.16% |
| Orbimed Advisors | 2,928,900 | $6,854,000 | 0.13% |